Cetera Advisor Networks’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$584K Buy
55,179
+2,128
+4% +$21.3K ﹤0.01% 1829
2023
Q4
$637K Buy
53,051
+14,743
+38% +$121K ﹤0.01% 1688
2023
Q3
$268K Sell
38,308
-400
-1% -$3.7K ﹤0.01% 2214
2023
Q2
$329K Buy
38,708
+2,625
+7% +$21.9K ﹤0.01% 2014
2023
Q1
$330K Buy
36,083
+13,056
+57% +$167K ﹤0.01% 1991
2022
Q4
$263K Buy
23,027
+7,724
+50% +$114K ﹤0.01% 2084
2022
Q3
$260K Buy
+15,303
New +$328K ﹤0.01% 1692
2022
Q2
Sell
-7,510
Closed -$278K 2089
2022
Q1
$278K Buy
7,510
+2,850
+61% +$111K ﹤0.01% 1675
2021
Q4
$212K Buy
4,660
+1,050
+29% +$54.8K ﹤0.01% 1841
2021
Q3
$229K Buy
3,610
+300
+9% +$22.8K ﹤0.01% 1711
2021
Q2
$303K Buy
+3,310
New +$263K ﹤0.01% 1491

Other funds holding CDNA

Cetera Advisor Networks's CDNA Position: Q1 2024 in Review

Cetera Advisor Networks increased its CareDx (CDNA) stake by 4% in Q1 2024, buying an estimated $21.3K and bringing the position to 55,179 shares worth $584K. The position accounts for ﹤0.01% of the portfolio, ranked #1829.

Cetera Advisor Networks first reported a position in CDNA in Q2 2021 and has held it in 11 quarters since. The position peaked at $637K in Q4 2023. 147 funds tracked by Wall St. Rank hold CDNA as of Q1 2024.

  • Cetera Advisor Networks held 55,179 shares of CareDx worth $584K as of Q1 2024.
  • Cetera Advisor Networks bought 2,128 CareDx shares in Q1 2024, an estimated $21.3K.
  • CareDx made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1829 holding.
  • Cetera Advisor Networks first reported a position in CareDx in Q2 2021 and has held it in 11 quarters since.
  • Cetera Advisor Networks's CareDx position peaked at $637K in Q4 2023.
  • 147 funds tracked by Wall St. Rank held CareDx as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.